Trials / Conditions / Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7
3 registered clinical trials studyying Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, St NCT00408694 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or NCT00336063 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal NCT00274937 | Children's Oncology Group | Phase 3 |